Brief: Cyclo Therapeutics Provides Business Update And Reports Full Year 2021 Financial Results
14/03/2022 12:24
March 14 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FULL
YEAR 2021 FINANCIAL RESULTS
* CYCLO THERAPEUTICS - EXPECTS TO COMMENCE PHASE 2 STUDY OF
INTRAVENOUS TRAPPSOL® CYCLO™ AND ENROLL PATIENTS IN 2022
* CYCLO THERAPEUTICS - CO ENDED YEAR WITH ABOUT $16.6
MILLION OF
CASH
* CYCLO THERAPEUTICS - EXPECTS RESEARCH AND DEVELOPMENT
COSTS TO
FURTHER INCREASE IN 2022
Source text for Eikon: ID:nBw6DGNDJa
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug